Axsome Therapeutics Stock In A Buy Zone. Analysts See Profit On The Horizon.

Published 5 days ago Positive
Axsome Therapeutics Stock In A Buy Zone. Analysts See Profit On The Horizon.
Auto
Axsome Therapeutics stock is in a buy zone and is up about 58% this year. The company's biggest revenue generator is a depression treatment.

Continue Reading

View Comments

More News

Þuríður Björg Guðnadóttir Appointed CEO of Ljósleiðarinn

3 hours ago Positive

Saudi Arabia Plastic Recycling Market Analysis Report 2025-2034: Increasing Demand for Polyethylene Terephthalate (PET) to Aid Growth

3 hours ago Positive

Uxin joins hand with Yinchuan authorities for used car superstore

3 hours ago Positive

Saudi Arabia Pet Care Analysis, Forecast Trends and Outlook Report 2025-2034: Market to Grow at a CAGR of 7.2%, Fueled by Growing Birds Segment and Increasing Affordability of Pet Care Products

3 hours ago Positive

Intelligent Network Market Set to Reach USD 42.2 Billion by 2032, Growing at a CAGR of 27.49% | Research by SNS Insider

3 hours ago Positive